Skip to main content

Jazz: Q4 Earnings Snapshot

DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported fourth-quarter earnings of $203.5 million.

The Dublin-based company said it had profit of $3.21 per share. Earnings, adjusted for one-time gains and costs, came to $6.64 per share.

The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $6.62 per share.

The drugmaker posted revenue of $1.2 billion in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $1.18 billion.

For the year, the company reported a loss of $356.1 million, or $5.84 per share. Revenue was reported as $4.27 billion.

Jazz expects full-year revenue in the range of $4.25 billion to $4.5 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story

Related News

Knicks take 1-0 lead into game 2 against the Spurs

Beijing bans 4 New Zealand lawmakers from entering China because they visited Taiwan

Police warn families of Tiananmen crackdown dead not to visit graves on 37th anniversary